Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

(2010) Carlo Riccardo Rossi et al.   ANNALS OF SURGICAL ONCOLOGY

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surgery and radiotherapy in the treatment of cutaneous melanoma

(2009) A. Testori et al.   ANNALS OF ONCOLOGY

Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters

(2009) H. Richard Alexander et al.   JOURNAL OF CLINICAL ONCOLOGY

Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases

(2008) Nanda Kandamany et al.   LASERS IN MEDICAL SCIENCE

Electrochemotherapy in treatment of tumours

(2007) G. Sersa et al.   EJSO